Ligand validation:5ELD

GAL: beta-D-galactopyranose

GAL is a Ligand Of Interest in 5ELD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5ELD_GAL_E_202	60%	58%	0.117	0.901	0.65	0.97	-	-	0	0	100%	0.3
5ELD_GAL_A_202	15%	54%	0.174	0.733	1.05	0.72	1	-	0	0	100%	0.7
5ELD_GAL_C_203	8%	46%	0.261	0.738	1.21	0.87	1	-	1	0	100%	0.8
5ELB_GAL_C_202	100%	58%	0.036	0.992	0.82	0.8	-	-	0	0	100%	0.6
8OXS_GAL_C_202	92%	70%	0.083	0.973	0.51	0.65	-	-	1	0	100%	0.5
7LVB_GAL_I_201	79%	66%	0.111	0.956	0.69	0.61	-	-	0	0	100%	1
1G8Z_GAL_H_104	49%	44%	0.182	0.929	0.83	1.31	-	2	0	0	100%	1
1S5E_GAL_D_751	24%	64%	0.201	0.832	0.64	0.72	-	-	0	0	100%	1
4WWH_GAL_A_401	100%	64%	0.026	0.99	0.47	0.9	-	-	0	0	100%	1
3OGR_GAL_A_1024	99%	47%	0.053	0.987	0.79	1.26	-	1	1	0	100%	1
1NSX_GAL_B_2400	98%	50%	0.055	0.981	0.56	1.36	-	3	0	0	100%	1
4LKF_GAL_A_201	98%	55%	0.045	0.984	0.92	0.83	-	-	0	0	92%	0.9167
5DVJ_GAL_B_501	98%	40%	0.047	0.968	0.95	1.38	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.